Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8 Melanoma 6 Carcinoma, Non-Small-Cell Lung 5 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Renal Cell 2 Advanced Solid Tumors 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma 1 Primary Condition: Advanced Tumors 1 Neuroendocrine Tumors 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer 1 Kidney Neoplasms 1 High-Risk Resectable NSCLC 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Tumours × toripalimab × Clear all

NCT04737122 2023-10-10

Study of LM-061 in Subjects in Advanced Tumors

LaNova Medicines Limited

Phase 1 Terminated

Advanced Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡